Department of Medicine, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia.
Departments of Radiation Oncology and Medical Ethics and Health Policy, University of Pennsylvania.
JAMA Netw Open. 2020 Aug 3;3(8):e2012569. doi: 10.1001/jamanetworkopen.2020.12569.
This economic evaluation explores how Medicare’s new technology add-on payment program (NTAP), which provides reimbursement for newly available drugs and devices, has changed during its lifetime since its initiation in 2013.
本经济评估探讨了自 2013 年启动以来,医疗保险新技术附加支付计划(NTAP)如何在其整个生命周期内发生变化,该计划为新可用的药物和设备提供报销。